Towards Reduction or Substitution of Cytotoxic DMSO in Biobanking of Functional Bioengineered Megakaryocytes.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Wolkers, Willem F
Guzmán, Carlos A
MetadataShow full item record
AbstractDonor platelet transfusion is currently the only efficient treatment of life-threatening thrombocytopenia, but it is highly challenged by immunological, quality, and contamination issues, as well as short shelf life of the donor material. Ex vivo produced megakaryocytes and platelets represent a promising alternative strategy to the conventional platelet transfusion. However, practical implementation of such strategy demands availability of reliable biobanking techniques, which would permit eliminating continuous cell culture maintenance, ensure time for quality testing, enable stock management and logistics, as well as availability in a ready-to-use manner. At the same time, protocols applying DMSO-based cryopreservation media were associated with increased risks of adverse long-term side effects after patient use. Here, we show the possibility to develop cryopreservation techniques for iPSC-derived megakaryocytes under defined xeno-free conditions with significant reduction or complete elimination of DMSO. Comprehensive phenotypic and functional in vitro characterization of megakaryocytes has been performed before and after cryopreservation. Megakaryocytes cryopreserved DMSO-free, or using low DMSO concentrations, showed the capability to produce platelets in vivo after transfusion in a mouse model. These findings propose biobanking approaches essential for development of megakaryocyte-based replacement and regenerative therapies.
CitationInt J Mol Sci. 2020 Oct 16;21(20):7654. doi: 10.3390/ijms21207654.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
- Isolation, Cryopreservation, and Characterization of iPSC-Derived Megakaryocytes.
- Authors: Pogozhykh D, Blasczyk R, Figueiredo C
- Issue date: 2021
- Polyunsaturated fatty acids confer cryoresistance on megakaryocytes generated from cord blood and also enhance megakaryocyte production from cryopreserved cord blood cells.
- Authors: Shabrani NC, Khan NF, Kale VP, Limaye LS
- Issue date: 2012 Mar
- Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
- Authors: Gao DY, Neff K, Xiao HY, Matsubayashi H, Cui XD, Bonderman P, Bonderman D, Harvey K, McIntyre JA, Critser J, Miraglia CC, Reid T
- Issue date: 1999 May
- [Morphologic and functional changes in thrombocytes after deep freezing with DMSO].
- Authors: Böck M, Greither L, Heim MU
- Issue date: 1996 Apr
- Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function.
- Authors: Balduini CL, Mazzucco M, Sinigaglia F, Grignani G, Bertolino G, Noris P, Pacchiarini L, Torti M, Salvaneschi L
- Issue date: 1993 Mar-Apr